Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Updated Results from DIAMOND-01 (CLI24-001) Trial: A Phase I/II Study of SEL24/MEN1703, a First-in-class Dual PIM/FLT3 Kinase Inhibitor, in Acute Myeloid Leukemia.

Scott R. Solomon,Pau Montesinos,Aziz Nazha,Stephen Anthony Strickland,Giovanni Martinelli,Armando Santoro,Roland B. Walter,Rachel J. Cook,Maria Calbacho,Susana Vives,Salman Fazal,Krzysztof Brzozka,Setareh Shamsili,Simone Baldini,Dirk Laurent, Andrea Ugo Enrico Pellacani,Farhad Ravandi

JOURNAL OF CLINICAL ONCOLOGY（2021）

Cited 3|Views26

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined